≥99.5% PURITY·HPLC VERIFIED·MASS SPEC CONFIRMED·USA SYNTHESIZED
Retatrutide
Triple GLP-1 / GIP / Glucagon Agonist
$139.00
· per vial≥99.5%HPLCRUO
IN STOCK · SHIPS TODAY58 of batch remaining
- Batch
- VR-26-04-RET-01
- Sealed
- Apr 19, 2026
- Sequence
- 39-amino-acid synthetic peptide (γGlu-C20 fatty acid side chain)
- Molecular Weight
- 4731.0 g/mol
- CAS Number
- 2381089-83-2
- Appearance
- White lyophilized powder
- Storage
- −20°C, protected from light
Research Areas
- · Triple incretin receptor pharmacology
- · Hepatic and adipose metabolic studies
- · Energy expenditure research models
Quantity
1
⚠ For research use only. Not for human consumption.
Not approved by the FDA. Not for diagnostic use.
Not approved by the FDA. Not for diagnostic use.
Retatrutide (LY-3437943) is a synthetic 39-amino-acid peptide and the first triple agonist of the GLP-1, GIP, and glucagon receptors to enter advanced clinical research.